Protherics PLC
Notification of Major Interests in Shares
London, UK; Brentwood, TN, US: 13 June 2008 - Protherics PLC
("Protherics" or the "Company"), the international biopharmaceutical
company focused on critical care and cancer, announces that today, in
accordance with the Transparency Obligations
Directive, a notification of interest in the ordinary share capital of
the Company was received from Invesco Perpetual on behalf of Perpetual
Income and Growth Investment Trust. Details of
the interest notified are as follows:
1. Reason for the notification (please tick the appropriate box or
boxes)
An disposal of voting rights Yes
An acquisition or disposal of financial instruments which may
result in the acquisition of shares already issued to which voting
rights are attached
An event changing the breakdown of voting rights
Other (please specify):
2. Full name of person(s) subject to the Perpetual Income and
notification obligation: Growth Investment
Trust
3. Full name of shareholder(s) (if different from 2.):
4. Date of the transaction (and date on which the 12 June 2008
threshold is crossed or reached if different):
5. Date on which issuer notified: 13 June 2008
6. Threshold(s) that is/are crossed or reached: crossed 4% threshold
into 3%
7. Notified details:
A: Voting rights attached to shares
Class/type of Situation previous Resulting situation after the triggering
shares to the Triggering transaction
transaction
if possible
using the ISIN Number of Number of Number of Number of voting % of voting
CODE Shares Voting shares rights rights
Rights
Direct Indirect Direct
Indirect
14,348,079 14,348,079 13,568,085 13,568,085 3.98%
Ordinary 2P
Shares
(GB0007029209)
B: Financial Instruments
Resulting situation after the triggering transaction
Type of Expiration Exercise/ Number of voting rights that % of
financial date Conversion may be acquired if the voting
instrument Period/ instrument is exercised/ rights
Date converted.
Total (A+B)
Number of voting rights % of voting rights
13,568,085 3.98%
8. Chain of controlled undertakings through which the voting rights and
/or the financial instruments are effectively held, if applicable :
Name of Company/Fund Number of % of issued
Shares share capital
Citibank 13,568,085 3.98%
Proxy Voting:
9. Name of the proxy holder:
10. Number of voting rights proxy holder will cease to hold:
11. Date on which proxy holder will cease to hold voting rights:
12. Additional information:
/ Ends /
For further information please contact:
Protherics
Nick Staples, Director of Corporate Affairs +44 (0) 7919 480510
Julie Vickers, Company Secretary +44 (0)1928 518010
Financial Dynamics - press enquiries
London: Ben Atwell, Lara Mott +44 (0) 20 7831 3113
New York: John Capodanno, Jonathan Birt +1 212 850 5600
Or visit www.protherics.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
Contact Information: Contacts: RNS Customer Services 0044-207797-4400 http://www.rns.com